Drugs Made In America Acquisition II Corp. (DMII)
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Sector: Blank Checks
Industry: Financial - Conglomerates
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ:DMIIFinancial Services · Financial - Conglomerates
+0.00%$10.19
AH Close$10.19+0.00%vs close
AH Close$10.19+0.00%vs close
Mkt Cap$649.1M
Float60.34M
O/S63.7M
Inst Own71.4%
SI0.2%
Dilution
MCap$649.1M
Float60.34M
O/S63.7M
Dilution